Description
Product details
LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short. Product Description and Composition LINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk. This unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically. Mechanism of Action The triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake. Synergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance. Uses and Indications LINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy. Prescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation. Key Benefits LINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management: Superior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects. Weight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect. Cardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes. Low Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas. Convenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond. Blood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg. These benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs. Side Effects Common side effects mirror individual components but occur less due to synergy: Gastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly. Genitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene. Volume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics. Serious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation. Side Effect Category Frequency Management Nausea and Diarrhea Common (10%) Take with food, slow titration UTI/Mycotic Infections Common (7%) Hydration, antifungals Hypoglycemia Rare (<2%) With insulin, dose adjust Lactic Acidosis Very Rare. Avoid in renal/hepatic failure Ketoacidosis Rare (0.1%) Check ketones if nausea Dosage and Administration Start with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity. Missed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use. Precautions and Warnings Assess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated. Drug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure. Frequently Asked Questions What is LINALIGIP EMPAMET used for? Controls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity. Does it cause weight gain? No—it promotes 2-4 kg loss, unlike some antidiabetics. Safe for kidneys? Renal-protective; monitor eGFR. Hypoglycemia risk? Minimal without sulfonylureas. Conclusion LINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.
![Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.
Product Snapshot
Brand: BISOGARD 1.25
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India
Active ingredient: Bisoprolol Fumarate 1.25mg
Form: Tablet
Pack size: 15 tablets
Drug class: Cardioselective beta-1 blocker
Legal status: Schedule H (valid prescription required)
Availability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India
What Is Bisoprolol 1.25mg?
If your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.
The 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.
What Is Bisoprolol 1.25mg Used For?
Doctors commonly prescribe this strength for:
Chronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics
High blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs
Stable angina: to reduce the heart's oxygen demand and relieve chest discomfort
After a heart attack: in selected patients, under a cardiologist's care
Heart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate
At 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).
How Does Bisoprolol Work?
Bisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:
Slower heart rate: the heart has more time to fill and rest between beats
Gentler contractions: the heart muscle needs less oxygen and energy
Less renin from the kidneys: this helps blood pressure fall gradually over time
Lower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure
Key Benefits of BISOGARD 1.25
A gentle starting dose, well suited to careful titration in frail or elderly patients
Heart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers
Once-daily dosing, which makes it easier to stay on treatment
A guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]
Made by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards
Dosage Guidance
Usual starting dose (heart failure): 1.25mg once a day, preferably in the morning
Dose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure
High blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor
How to take it: at the same time every day, with or without food, swallowed whole with water
If you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.
Never stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.
Is It Better to Take Bisoprolol in the Morning or at Night?
Most doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.
Side Effects of Bisoprolol 1.25mg
Common side effects
Tiredness or fatigue
Dizziness or light-headedness, especially on standing quickly
Cold hands or feet
Slow pulse (bradycardia)
Headache
Mild stomach upset (nausea, loose stools)
Disturbed sleep
Serious side effects (get medical help promptly)
Very slow heartbeat or fainting
Increasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening
Allergic reaction: rash, swelling of the face or throat, trouble breathing
Cold, numb, or bluish fingers and toes
Wheezing or new breathing difficulty, particularly in people with asthma or COPD
Mood changes, low mood, or confusion
What Are the Bad Side Effects of Bisoprolol?
The effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]
Substitutes & Comparable Beta-Blockers
Molecule Selectivity Typical Use Case
Bisoprolol Highly cardioselective Heart failure titration, hypertension
Metoprolol Succinate ER Cardioselective Hypertension, angina, heart failure
Atenolol Cardioselective (older agent) Hypertension
Carvedilol Non-selective with alpha-blocking action Heart failure (adds vasodilation)
Propranolol Non-selective Migraine prevention, anxiety-related fast heartbeat, essential tremor
Precautions & Who Should Avoid Bisoprolol
Not suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma
Use carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar
Take care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen
Never stop it abruptly; always taper under a doctor's guidance
Tell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics
In pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks
Is Bisoprolol Safe for Kidneys?
The body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.
Is Bisoprolol a High-Risk Medication?
Bisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.
Does 1.25mg Bisoprolol Lower Blood Pressure?
Yes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.
Frequently Asked Questions
1. What is 1.25 mg of bisoprolol used for?
Mainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.
2. What are the bad side effects of bisoprolol?
The more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.
3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?
Tiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.
4. Is it better to take bisoprolol in the morning or at night?
Morning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.
5. What is the cost of bisoprolol?
Price depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.
6. Does 1.25 mg bisoprolol lower blood pressure?
Yes, though only modestly at this dose. The dose is often stepped up over time.
7. Is bisoprolol safe for kidneys?
Generally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.
8. Is bisoprolol a high-risk medication?
It is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.
9. Can I take bisoprolol 1.25mg for the rest of my life?
Many people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.
10. What happens if I miss a dose of bisoprolol?
Take it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.
11. Can bisoprolol 1.25mg cause weight gain?
It is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.
12. Is bisoprolol safe for diabetic patients?
It can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.
13. Can I stop taking bisoprolol suddenly if I feel fine?
No. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.
14. Does bisoprolol interact with other blood pressure medicines?
Yes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.
15. Is BISOGARD 1.25 available without a prescription?
No. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.
16. How long does it take for bisoprolol 1.25mg to start working?
Some effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.
17. Can pregnant women take bisoprolol?
Only if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.](https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png)
